A Combination of Sorafenib, an Immune Checkpoint Inhibitor, TACE and Stereotactic Body Radiation Therapy versus Sorafenib and TACE in Advanced Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombus

A Combination of Sorafenib, an Immune Checkpoint Inhibitor, TACE and Stereotactic Body Radiation Therapy versus Sorafenib and TACE in Advanced Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombus

Background: This study compared the effectiveness of the combined administration of sorafenib, an immune checkpoint inhibitor, transcatheter arterial chemoembolization (TACE), and stereotactic body radiation therapy (SBRT) (SITS group) vs. sorafenib combined with TACE (ST group) in treating and down...

Full description

Bibliographic Details
Main Authors: Zeyu Zhang, Chan Li, Weijun Liao, Yun Huang, Zhiming Wang
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Cancers
Subjects:
downstaging
hepatocellular carcinoma
sorafenib
stereotactic body radiation therapy
transcatheter arterial chemoembolization
immune checkpoint inhibitor
Online Access:https://www.mdpi.com/2072-6694/14/15/3619

Internet

https://www.mdpi.com/2072-6694/14/15/3619

Similar Items